Antisense oligonucleotide modulation of MDR P-glycoprotein gene

Details Antisense oligonucleotide modulation of MDR P-glycoprotein gene Antisense oligonucleotide modulation of MDR P-glycoprotein gene

1997-09-30

1999-12-14

Degen, Nancy

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536 231, 536 2431, 435 6, C07H 2104, C12Q 168

Patent

active

060019913

ABSTRACT:
Oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding the human MDR1 P-glycoprotein. Also disclosed are methods of using the oligonucleotides of the invention in methods of modulating the expression of MDR genes, inhibition of which leads to inhibition of the synthesis of MDR P-glycoproteins and thereby inhibits cellular multidrug resistance. Such inhibition is desirable for treating various hyperproliferative disorders or diseases, such as various cancers, in conjunction with chemotherapy utilizing one or more chemotherapeutic agents, for preventing or modulating the development of multidrug resistance during the chemotherapeutic treatment of an animal, and for resensitizing hyperproliferative MDR cells in an animal having such diseases or disorders that has been previously exposed to chemotherapeutic agents. Modified derivatives of the oligonucleotides of the invention, such as chimeras and conjugates (e.g., of an oligonucleotide and a lipophilic moiety, such as cholesterol), are also disclosed. The biological activity and cellular uptake of oligonucleotides is enhanced by such modifications.

REFERENCES:
patent: 4689320 (1987-08-01), Kaji
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5087617 (1992-02-01), Smith
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5135917 (1992-08-01), Burch
patent: 5138045 (1992-08-01), Cook et al.
patent: 5166195 (1992-11-01), Ecker
patent: 5194428 (1993-03-01), Agrawal et al.
patent: 5218105 (1993-06-01), Cook et al.
patent: 5242906 (1993-09-01), Pagano et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5459255 (1995-10-01), Cook et al.
patent: 5510239 (1996-04-01), Baracchini, Jr. et al.
patent: 5683987 (1997-11-01), Smith
Akhtar et al., Cellular uptake and intracellular fate of antisense oligonucleotides. Trends in Cell Biology, 1992, 2, 139.
Alahari et al., "The fission yeast prp4.sup.+ gene involved in pre-mRNA splicing codes for a predicted serine/threonine kinase and is essential for growth", Nucl. Acids Res., 1993, 21, 4079.
Bennett et al,. "Cationic Lipids Enhance Cellular Uptake and Activity of Phosphorothioate Antisense Oligonucleotides", Mol. Pharm., 1992, 41, 1023.
Berkow et al., eds., The Merck Manual of Diagnosis and Therapy, 15th Ed., Rahay, N.J., 1987, pp. 1206-1228.
Bradley et al., "P-glycoprotein, multidrug resistance and tumor progression", Cancer Metastasis Rev., 1994, 13, 223.
Brigstock et al., "Species-Specific High Molecular Weight Forms of Basic Fibroblast Growth Factor", Growth Factors, 1990, 4, 45.
Chabner et al., "Reversal of Multidrug Resistance", J. Clin. Oncol., 1991, 9, 4.
Chen et al., "Genomic Organization of the Human Multidrug Resistance (MDRI) Gene and Origin of P-glycoproteins", J. Biol. Chem., 1990, 265, 506.
Corrias et al., "An Oligomer Complementary to the 5' End Region of MDR1 Gene Decreases Resistance to Doxorubicin of Human Adenocarcinoma-Resistant Cells", Anticancer Res., 1992, 12, 1431.
Crooke et al., "Pharmacokinetic Properties of Several Novel Oligonucleotide Analogs in mice", J. Pharmacol. Exp. Ther., 1996, 277, 923.
Dean et al., "Inhibition of Protein Kinase C-.alpha. Expression in Human A549 Cells by Antisense Oligonucleotides Inhibits Induction of Intercellular Adhesion Molecule 1 (ICAM-1) mRNA by Phorbol Esters", J. Biol. Chem., 1994, 269.
De Virgilio et al., "Cloning and Disruption of a Gene Required for Growth on Acetate but not on Ethanol: The Acetyl-Coenzyme A Synthetase Gene of Saccharomyces cerevisiae", Yeast, 1992, 8, 1043.
Efferth et al., "Modulation of P-Glycoprotein-Mediated Multidrug Resistance by Monoclonal Antibodies, Immunotoxins of Antisense Oligodeoxynucleotides in Kidney Carcinoma and Normal Kidney Cells", Oncol., 1993, 50, 303.
French et al., "Expression of Two Related Nonstructural Proteins of Bluetongue Virus (BTV) Type 10 in Insect Cells by a Recombinant Baculovirus: Production of Polyclonal Ascitic Fluid and Characterization of the Gene Product in BTV-Infected BHK Cells," J. Virol., 1989, 63, 3270.
Gao et al., "Cloning and Characterization of a Mouse Gene with Homology to the Human von Hippel-Lindau Disease Tumor Suppressor Gene: Implications for the Potential Organization of the Human von Hippel-Lindau Disease Gene", Cancer Res., 1995, 55, 743.
Gelbert et al., "Analysis of GPT Activity in Mammalian Cells with a Chromosomally Integrated Shuttle Vector Containing Altered gpt Genes", Somat. Cell. Mol. Genet., 1990, 16, 173.
Gold and Stormo, in : Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology, vol. 2, 1987, Neidhardt et al., eds., American Society for Microbiology, Washington, D.C., p. 1303.
Gottesman et al., "The Multidrug Transporter, a Double-edged Sword", J. Biol. Chem., 1988, 263, 12163.
Ho et al., "Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries", Nucl. Acids Res., 1996, 24, 1901.
Ishida et al., "Multidrug Resistance in Cultured Human Leukemia and Lymphoma Cell Lines Detected by a Monoclonal Antibody, MRK16", Jpn. J. Cancer Res., 1989, 80, 1006.
Kabanov et al., "A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells", FEBS Lett., 1990, 259, 327.
Kanagasundaram et al., "Isolation and characterization of the gene encoding gluconolactonase from Zymomonas mobilis", Biochim. Biophys. Acta, 1992, 1171, 198.
Kane et al., "A new vector using the human multidrug resistance gene as a selectable marker enables overexpression of foreign genes in eukaryotic cells", Gene, 1989, 84, 439.
Kaji et al., "Structurally Distinct MDR Modulators Show Specific Patterns of Reversal against P-Glycoproteins Bearing Unique Mutations at Serine.sup.939/941 ", Biochem., 1994, 33, 5041.
Kiehntopf et al., "Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells", EMBO J., 1994, 13, 4645.
Kobayashi et al., "Reversal of Drug Sensitivity in Multidrug-Resistant Tumor Cells by an MDR1 (PGY1) Ribozyme", Cancer Res., 1994, 54, 1271.
Krieg et al., "Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular assocation and improves efficacy", Proc. Natl. Acad. Sci. USA, 1993, 90, 1048.
Letsinger et al., Proc. Natl. Acad. Sci. USA, 1989, 86, 6553.
MacKellar et al., "Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups", Nucl. Acids Res., 1992, 20, 3411.
Manoharan et al., "Introduction of a Lipophilic Thioether Tether in the Minor Groove of Nucleic Acids for Antisense Applications", Bioorg. Med. Chem. Let., 1993, 3, 2765.
Manoharan et al., "Lipidic Nucleic Acids", Tetrahedron Lett., 1995, 36, 3651.
Manoharan et al., "Oligonucleotide Conjugates: Alteration of the Pharmacokinetic Properties of Antisense Agents", Nucleosides & Nucleotides, 1995, 14, 969.
Manoharan et al., "Cholic Acid-Oligonucleotide Conjugates for Antisense Applications", Bioorg. Med. Chem. Let., 1994, 4, 1053.
Manoharan et al., "Chemical Modifications to Improve Uptake and Bioavailability of Antisense Oligonucleotides", Ann. N.Y. Acad. Sci., 1992, 660, 306.
Martin et al., "Ein neuer Zugang zu 2'-O-AlkyIribonucleosiden und Eigenschaften deren Oligonucleotide", Helv. Chim. Acta, 1995, 78, 486.
Markussen et al., "Translational control of oskar generates Short OSK, the isoform that induces pole plasm assembly", Development, 1995, 121, 3723.
McDermott et al., "Structure and lens expression of the gene encoding chicken .beta.A3/A1-crystallin", Gene, 1992, 117, 193.
Mishra et al., "Improved leishmanicidal effect of phosphorotioate antisense oligonucleotides by LDL-mediated delivery", Biochim. Biophys. Acta, 1995, 1264, 229.
Monaco et al., "Structure of Two Rat Genes Coding for Closely Related Rolipram-sensitive cAMP Phospho

Affiliated with

Also associated with

Rating

Antisense oligonucleotide modulation of MDR P-glycoprotein gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotide modulation of MDR P-glycoprotein gene , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide modulation of MDR P-glycoprotein gene will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-864769